Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019.
Título
Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019.
Autor
Nicholas Hartog, Amanda Holsworth, Surender Rajasekaran
Fecha
2021
Identificador
10.1016/j.anai.2020.11.005
Fuente
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Archivos
Colección
Citación
Nicholas Hartog, Amanda Holsworth, Surender Rajasekaran, “Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019.,” SOCICT Open, consulta 23 de abril de 2026, https://socictopen.socict.org/items/show/8037.
Position: 9511 (26 views)